The Latest Breaking News on Pharma

Tasmanian police arrest a man and seize thousands of colourful MDMA pills worth hundreds of thousands of dollars in a pre-Christmas bust.

The alleged kingpin of a global drug trafficking syndicate has appeared in a Melbourne court after being extradited from the Netherlands to face justice.

Canadian national Tse Chi Lop is extradited to Melbourne from the Netherlands to face charges of conspiracy to traffic commercial quantities of controlled drugs.

A 47-year-old Hobart man has been charged after police seized more than 11,000 MDMA pills, worth about $400,000, along with drug manufacturing equipment.

Several soldiers are arrested in Gambia over a foiled alleged coup plot. Authorities say they're in pursuit of three other suspected accomplices. Also in Gambia, a parliamentary committee recommends that the government ban and prosecute an Indian pharmaceutical company accused of causing the deaths of at least 70 children. And…

Merit delivered the milestone three years faster than the biotech industry standard of around five years

More than 397 million fatal fentanyl doses have been intercepted this year with just two milligrams enough to be deadly, according to the Drug Enforcement Administration

The need for more advanced biotech research and development has increased amid an aging population and growing medical needs. Investors' sentiment toward biotech stocks has improved significantly over the past months. Given the industry's solid prospects, fundamentally sound biotech stocks Exelixis (EXEL), Innoviva (INVA), and Cidara Therapeutics (CDTX) might be…

Berlin has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, a German government spokesperson said on Wednesday, the first foreign coronavirus vaccine to be delivered to the country.

The Hague (AFP) - Under-fire Dutch medical device maker Philips said Wednesday extensive testing on its recalled respirator devices showed they were "within safety limits" for use, but that a final verdict rests with global regulatory authorities.

The antiviral drug Paxlovid will be gradually made available at all medical institutions and at the community level, says head of the infectious diseases department at Peking University First Hospital